Serial #79275205
LIVE

Serial Number

79275205

Owner

HitGen Inc.

Attorney

Eric J Maiers

Filing Date

Jul 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79275205 Trademark

Serial Number: 79275205 • Registration: 6382632

Serial #79275205 is a trademark filed by HitGen Inc. on July 9, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HitGen Inc. (6 trademarks)

Floor 3, Building 1, No. 88, Keyuan South Road,

Entity Type: 03

HITGEN LTD. (3 trademarks)

1001, UNIT 3,

Entity Type: 99

Trademark Details

Filing Date

July 9, 2019

Registration Date

June 15, 2021

Published for Opposition

March 30, 2021

Goods & Services

Technical project studies, namely, technical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research services relating to DNA encoded library synthesis, namely, DNA analysis services for scientific research purposes; research services relating to DNA encoded library selection, namely, DNA screening for scientific research purposes; research services relating to DNA encoded library data analysis, namely, DNA screening for forensic research purposes

Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical research

Medicines for human purpose, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases

Shop window dressing; outdoor advertising; bill-posting; distribution of samples; publicity services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 15, 2026 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 8, 2023 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 10, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 29, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 30, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 30, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 15, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 26, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 26, 2021 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 30, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 28, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 10, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 10, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 24, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 24, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 24, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 24, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 3, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 4, 2020 GNFN
FINAL REFUSAL E-MAILED
Aug 4, 2020 GNFR
FINAL REFUSAL WRITTEN
Aug 4, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 6, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 14, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 13, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 10, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 31, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2019 REPR